28 April 2023
For first-quarter 2023, Riber S.A. of Bezons, France – which manufactures molecular beam epitaxy (MBE) systems as well as evaporation sources – has reported revenue of €3.7m, up 54% on €2.4m a year ago.
MBE systems revenue was €1.9m (comprising billing for one research system), compared with nil a year ago.
Services & Accessories revenue has fallen by 23% from €2.4m to €1.8m.
Of total revenue, 15% came from Europe, 27% in Asia, 6% in North America and 51% in other countries.
Order book up 45% year-on-year
The order book totaled €33.1m at the end of March, up 45% from €22.8m at end-March 2022, driven by the increase in industrial demand for both R&D and production.
Specifically, orders for MBE systems are up by 60% from €16.7m to €26.7m, comprising 11 machines (including four production machines). This does not include the option to buy, announced on 8 June 2022, for four production machines. The Services & Accessories order book is up 5% from €6.2m to €6.5m.
Full-year outlook for 2023
In view of the strong order book (with a high proportion of machines deliverable in 2023), Riber is targeting full-year revenue of about €40m (up 44% on 2022’s €27.8m). This growth should be combined with an improvement in profitability.
Riber expects that, in a buoyant market context, it will continue taking orders during second-quarter 2023.
Riber reports full-year net profit, despite electronic component sourcing constraints
Riber receives order for MBE 6000 production system
Riber’s revenue halves in Q3, impacted by difficulties sourcing electronic components
Riber’s order book up 76% year-on-year to €30.6m at end-June
Riber’s revenue falls 25% in Q1 due to deferred billing for major Services & Accessories order